Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

A Monte Carlo investigation of lung brachytherapy treatment planning.

Sutherland JG, Furutani KM, Thomson RM.

Phys Med Biol. 2013 Jul 21;58(14):4763-80. doi: 10.1088/0031-9155/58/14/4763. Epub 2013 Jun 20.

PMID:
23788118
2.

Monte Carlo calculated doses to treatment volumes and organs at risk for permanent implant lung brachytherapy.

Sutherland JG, Furutani KM, Thomson RM.

Phys Med Biol. 2013 Oct 21;58(20):7061-80. doi: 10.1088/0031-9155/58/20/7061. Epub 2013 Sep 20.

PMID:
24051987
3.

Metallic artifact mitigation and organ-constrained tissue assignment for Monte Carlo calculations of permanent implant lung brachytherapy.

Sutherland JG, Miksys N, Furutani KM, Thomson RM.

Med Phys. 2014 Jan;41(1):011712. doi: 10.1118/1.4851555.

PMID:
24387504
4.

Sci-Sat AM: Brachy - 11: Improving treatment planning for I-125 lung brachytherapy using Monte Carlo methods.

Sutherland J, Furutani KM, Thomson RM.

Med Phys. 2012 Jul;39(7Part4):4646-4647. doi: 10.1118/1.4740218.

PMID:
28516652
5.

Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer.

Johnson M, Colonias A, Parda D, Trombetta M, Gayou O, Reitz B, Miften M.

Phys Med Biol. 2007 Mar 7;52(5):1237-45. Epub 2007 Jan 31.

PMID:
17301451
6.

Model-based dose calculations for (125)I lung brachytherapy.

Sutherland JG, Furutani KM, Garces YI, Thomson RM.

Med Phys. 2012 Jul;39(7):4365-77. doi: 10.1118/1.4729737.

PMID:
22830769
7.

Dose perturbation effects in prostate seed implant brachytherapy with I-125.

Mobit P, Badragan I.

Phys Med Biol. 2004 Jul 21;49(14):3171-8.

PMID:
15357190
8.

A simplified analytical dose calculation algorithm accounting for tissue heterogeneity for low-energy brachytherapy sources.

Mashouf S, Lechtman E, Beaulieu L, Verhaegen F, Keller BM, Ravi A, Pignol JP.

Phys Med Biol. 2013 Sep 21;58(18):6299-315. doi: 10.1088/0031-9155/58/18/6299. Epub 2013 Aug 22.

PMID:
23965939
9.

Dose verification with Monte Carlo technique for prostate brachytherapy implants with (125)I sources.

Zhang H, Baker C, McKinsey R, Meigooni A.

Med Dosim. 2005 Summer;30(2):85-91.

PMID:
15922174
10.

CT-based dosimetry calculations for 125I prostate implants.

DeMarco JJ, Smathers JB, Burnison CM, Ncube QK, Solberg TD.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1347-53.

PMID:
10613332
11.

Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.

Lesperance M, Martinov M, Thomson RM.

Med Phys. 2014 Mar;41(3):031706. doi: 10.1118/1.4864474.

PMID:
24593710
12.

Comparison of dose calculation methods for brachytherapy of intraocular tumors.

Rivard MJ, Chiu-Tsao ST, Finger PT, Meigooni AS, Melhus CS, Mourtada F, Napolitano ME, Rogers DW, Thomson RM, Nath R.

Med Phys. 2011 Jan;38(1):306-16.

13.

Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation.

Beaulieu L, Carlsson Tedgren A, Carrier JF, Davis SD, Mourtada F, Rivard MJ, Thomson RM, Verhaegen F, Wareing TA, Williamson JF.

Med Phys. 2012 Oct;39(10):6208-36. doi: 10.1118/1.4747264.

PMID:
23039658
14.

The effect of patient inhomogeneities in oesophageal 192Ir HDR brachytherapy: a Monte Carlo and analytical dosimetry study.

Anagnostopoulos G, Baltas D, Pantelis E, Papagiannis P, Sakelliou L.

Phys Med Biol. 2004 Jun 21;49(12):2675-85.

PMID:
15272681
15.

Dose heterogeneity correction for low-energy brachytherapy sources using dual-energy CT images.

Mashouf S, Lechtman E, Lai P, Keller BM, Karotki A, Beachey DJ, Pignol JP.

Phys Med Biol. 2014 Sep 21;59(18):5305-16. doi: 10.1088/0031-9155/59/18/5305. Epub 2014 Aug 22.

PMID:
25146446
16.

Dosimetric aspects of 166Ho brachytherapy biodegradable glass seed.

Hosseini SH, Enferadi M, Sadeghi M.

Appl Radiat Isot. 2013 Mar;73:109-15. doi: 10.1016/j.apradiso.2012.12.002. Epub 2012 Dec 12.

PMID:
23313765
17.

Cesium-131 permanent seed brachytherapy: dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff.

Parashar B, Wernicke AG, Pavese A, Singh P, Trichter S, Sabbas A, Kutler DI, Kuhel W, Port JL, Lee PC, Nori D, Chao KS.

Brachytherapy. 2011 Nov-Dec;10(6):508-13. doi: 10.1016/j.brachy.2011.04.002. Epub 2011 Jun 2.

PMID:
21640663
18.

Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.

Lesperance M, Inglis-Whalen M, Thomson RM.

Med Phys. 2014 Feb;41(2):021717. doi: 10.1118/1.4861715.

PMID:
24506608
19.

Development of virtual patient models for permanent implant brachytherapy Monte Carlo dose calculations: interdependence of CT image artifact mitigation and tissue assignment.

Miksys N, Xu C, Beaulieu L, Thomson RM.

Phys Med Biol. 2015 Aug 7;60(15):6039-62. doi: 10.1088/0031-9155/60/15/6039. Epub 2015 Jul 28.

PMID:
26216174
20.

Robotic brachytherapy and sublobar resection for T1 non-small cell lung cancer in high-risk patients.

Blasberg JD, Belsley SJ, Schwartz GS, Evans A, Wernick I, Ashton RC Jr, Bhora FY, Connery CP.

Ann Thorac Surg. 2010 Feb;89(2):360-7. doi: 10.1016/j.athoracsur.2009.09.052.

PMID:
20103299

Supplemental Content

Support Center